K. Schaefer

发表

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

N. Hanania, J. Donohue, D. Pasta, 2008, Clinical therapeutics.

Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.

D. Mahler, J. Hanrahan, D. Tashkin, 2009, Respiratory medicine.

Treatment with (r)-albuterol Has No Advantage over Racemic Albuterol Detrimental Effects of B 2 -agonists

Ra, J. Dow, R. Baumgartner, 2022 .

Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.

H. Nelson, J. Roach, W. Pleskow, 2004, Allergy and asthma proceedings.

EFFECT OF ARFORMOTEROL TWICE DAILY, TIOTROPIUM ONCE DAILY, AND THEIR COMBINATION IN SUBJECTS WITH COPD

D. Mahler, J. Hanrahan, D. Tashkin, 2008 .

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference

C. Morin, Min Yang, G. Wallenstein, 2009, Current medical research and opinion.

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

A. Krystal, T. Roth, D. Amato, 2007, Sleep.

An Evaluation of Levalbuterol HFA in the Prevention of Exercise-Induced Bronchospasm

D. Pearlman, W. Andrews, W. Rees, 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.

R. Nowak, L. Vaickus, C. Emerman, 2004, The American journal of emergency medicine.

Evaluation of the Efficacy and Safety of Levalbuterol in Subjects with COPD

C. Andrews, J. Donohue, M. Parsey, 2006, COPD.

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.

S. Ancoli-Israel, A. Krystal, T. Roth, 2010, Sleep.

Cost Effectiveness of Long-Term Treatment with Eszopiclone for Primary Insomnia in Adults

C. Pashos, D. Foley, R. Ozminkowski, 2007, CNS drugs.

Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.

A. Pickard, M. Botteman, S. Snedecor, 2010, Journal of Mental Health Policy and Economics.

Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

A. Pickard, C. Bojke, M. Botteman, 2009, Sleep.

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

M. Pollack, A. Krystal, T. Roth, 2008, Archives of general psychiatry.

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

G. Zammit, M. Erman, D. Amato, 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.

R. Nowak, N. Hanania, J. Hanrahan, 2006, The American journal of emergency medicine.

Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia

A. Krystal, T. Roth, W. McCall, 2007, European psychiatry.

PNL30 FORECASTING THE IMPACT OF ADDING A NEW DRUG ON FORMULARY USING MEDICAL CLAIMS DATA AND CLINICAL LITERATURE: A CASE STUDY OF INSOMNIA TREATMENT

R. Ozminkowski, G. Lenhart, Shaohung S. Wang, 2005 .

Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.

M. Abelson, K. Schaefer, K. Schaefer, 1993, Survey of ophthalmology.

Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

C. Bojke, M. Botteman, S. Snedecor, 2009, Sleep.